EPHX1 and ERCC2 polymorphisms are associated with cisplatin-induced nephrotoxicity and prognosis in Thai cancer patients

Suggested Citation

Ahmed S., Eu-Ahsunthornwattana J., Thamrongjirapat T., Taweewongsounton A., Rittavee Y., Thokanit N.S., Ngodngamthaweesuk M., Hiranyatheb P., Reungwetwattana T., Ngamphaiboon N., Jinawath N. EPHX1 and ERCC2 polymorphisms are associated with cisplatin-induced nephrotoxicity and prognosis in Thai cancer patients. Plos One Vol.20 No.6 June (2025). doi:10.1371/journal.pone.0324699 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/110884

Availability

Collections